• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (PRINGY) VOLBELLA WITH LIDOCAINE; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (PRINGY) VOLBELLA WITH LIDOCAINE; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number 94728ED
Device Problem Shelf Life Exceeded (1567)
Patient Problems Edema (1820); Unspecified Infection (1930); Skin Irritation (2076)
Event Date 08/15/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4).The reporter has declined to provide allergan further information regarding event, product, or patient details.The events of infection, pimple, swelled and went hard are physiological complications and analysis of the device generally does not assist allergan in determining a probable cause for these events.Device history record summary: the documentary research in the batch file shows that no element could explain these reactions: all the manufacturing steps and all the physicochemical and microbiological results (endotoxins, bioburden) are registered as conforming to the specifications.The extrusion force value shows an expected consistency of the product.The sterilization cycle is registered as conforming.Device labeling for the reported events of edema, skin irritation, skin inflammation, infection and shelf-life exceeded: "contra-indications: juvéderm® volbella® with lidocaine must not be used in areas presenting cutaneous inflammatory and/or infectious processes (acne, herpes, etc.).Precautions for use: as a matter of general principle, injection of a medical device is associated with a risk of infection.Standard precautions associated with injectable materials should be followed.Undesirable effects: the patients must be informed that there are potential side effects associated with implantation of this product, which may occur immediately or may be delayed.These include, but are not limited to: inflammatory reactions (redness, oedema, erythema, etc.) which may be associated with itching, and/or pain on pressure and/or paraesthesia, occurring after the injection.These reactions may last for a week.In particular, it has to be noted that injection in the mucous membrane may cause more oedema and bruising due to the specific physiology of these tissues.Besides, a preventive anti-inflammatory treatment by a medical practitioner can be recommended.Induration or nodules at the injection site.Warnings: check the expiry date on the product label.Juvéderm® volbella® with lidocaine gel must be used prior to the expiration date printed on the package.".
 
Event Description
Healthcare professional reported injecting a patient with juvéderm® volbella® with lidocaine in the perioral and forehead as well as juvéderm® voluma® with lidocaine in the cheeks (no complaint with this injection).About 3 months later, the patient had their perioral area and forehead "flare up." the symptoms started as "a pimple on left side of the mouth and then swelled and then spread to right side - went hard." a biopsy was done by the patient's general practitioner and the results "showed nothing." patient was then put on antibiotics and the symptoms settled 2 weeks later.The healthcare professional was informed of the event about 2 weeks after symptoms first appeared and believes it was an "introduced infection." the injection with juvéderm® volbella® with lidocaine was injected 5 days after expiration.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VOLBELLA WITH LIDOCAINE
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy 74370
FR  74370
Manufacturer (Section G)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy 74370
FR   74370
Manufacturer Contact
suzanne wojcik
301 w howard lane
suite 100
austin, TX 78753
7372473605
MDR Report Key6581488
MDR Text Key75631284
Report Number3005113652-2017-00370
Device Sequence Number1
Product Code LMH
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
P110033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 05/22/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/22/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/30/2016
Device Catalogue Number94728ED
Device Lot NumberV15LA40157
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/02/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/16/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Treatment
JUVÉDERM® VOLUMA® WITH LIDOCAINE
Patient Outcome(s) Required Intervention;
Patient Age58 YR
-
-